Morgan Keegan

Morgan Keegan has published a research report on Apple (NASDAQ: AAPL) and has raised the price target from $650 to $800. In the report, Morgan Keegan writes, "We view these capital plans to be in line with our expectations of a $10.00 annual dividend and a modest buyback, however, we are raising...

What stress test? It appears there isn't much stress on Wall Street, at least not for lack of business, as three companies prepare to go public today. Demandware, an e-commerce software provider and Allison Transmission Holdings, a heavy-duty transmission manufacturer each get tickers,...

Morgan Keegan has published a research report on Hibbett Sports (NASDAQ: HIBB) and has raised the price target on the company from $50 to $59 after the company reported solid 4Q results. In the report, Morgan Keegan writes, "We are encouraged by the broad based sales strength, operating margin...

Morgan Keegan has published a research report on Teleflex Incorporated (NYSE: TFX) after the company announced its appointment of Thomas Powell as the Senior Vice President and Chief Financial Officer of the company. In the report, Morgan Keegan writes, "Teleflex announced the appointment of...

Morgan Keegan raises its rating on Solta Medical (NASDAQ: SLTM) to Outperform from Market Perform and raises its price target by 25 cents to $3.75 a share on positive field checks on LipoSonix. Morgan Keegan says, "We recently surveyed several US physicians who have trialed Solta's LipoSonix fat...

Morgan Keegan remains Market Perform-rated on Cedar Shipping Centers (NYSE: CDR) and raises its price target by 75 cents to $5 following solid Q4 operating trends. Morgan Keegan says, "During 4Q 2011, CDR executed 52 new and renewal leases aggregating approximately 228k SF of space—at an average...

Morgan Keegan cuts its rating on Main Street Capital Corporation (NYSE: MAIN) to Market Perform from Outperform, as it believes its solid Q4 and raised dividend are already priced into its current stock valuation. Price target is raised $3.50 to $24.50 a share on increased estimates. Morgan...

According to a research report published earlier today by Morgan Keegan, Covidien's (NYSE: COV) Peripheral Vascular Stent is already competing with C.R. Bard (NYSE: BCR). In the report, Morgan Keegan mentioned, “Covidien announced FDA clearance of the superficial femoral artery and proximal...

Morgan Keegan lowers its price target $4 to $30 on Outperform-rated Semtech Corporation (NASDAQ: SMTC) on near-term softness. Morgan Keegan says, " SMTC's Jan qtr results came in at $0.32/$104.0 million vs. consensus of $0.31/$105.2 million. All end markets declined sequentially during the qtr....

In a research report published earlier today, Morgan Keegan has lowered its estimates for Semtech Corporation (NASDAQ: SMTC), as the company has reported near-term softness. Morgan Keegan lowered Semtech's PT from $34 to $30. Morgan Keegan said in the report, “We are lowering our FY13 estimate to...

Morgan Keegan lowers its price target $1 to $30 on Perform-rated AeroVironment (NASDAQ: AVAV) as the company reports 3Q12 results. Morgan Keegan says, "AeroVironment had a much weaker than expected quarter due to a delay in customer acceptance of a $20 million Raven order. This order has by now...

Morgan Keegan has published a research report on Iridium Communications (NASDAQ: IRDM) and has raised the price target from $12 to $13 after the company reported 4Q earnings. In the report, Morgan Keegan writes, "Iridium had a solid quarter with slightly better than expected revenue and lower...

Morgan Keegan raises its price target to $69 on Outperform-rated QUALCOMM (NASDAQ: QCOM) as the company increases dividend 16 percent and announces new $4billion stock buyback. Morgan Keegan notes, "Qualcomm announced a 16% increase in its cash quarterly dividend to $0.25/ or $1.00/year from $0....

Morgan Keegan cuts its rating on Copano Energy (NYSE: CPNO) to Perform on lower 2012 guidance and valuation. Price target also falls $1 to $38. Morgan Keegan notes, "CPNO announced on its Q4 conf call that it is experiencing operational difficulties at its Houston Central plant that it expects...

According to a research report published earlier today, Morgan Keegan increased Sun Healthcare Group's (NASDAQ: SUNH) PT from $4.25 to $5. Morgan Keegan commented in the report, “Sun Healthcare Group reported EPS (before a nonrecurring receivables writeoff) of $0.07 per share, well ahead of our...